Table 1.
Characteristics | Panel I | |
---|---|---|
Type of sample | FFPE-DNA | |
Amplicon length, bp | 125–175 | |
Amplicons designed | 399 (X 2) | |
Common genes included (pituitary adenoma and DTC) | 1. AIP (NM_003977): exon 1–6; | |
2. BRAF (NM_004333): exon 15; | ||
3. CDKN1B (NM_ 004064): exon 1–2 | ||
4. GNAS (NM_016592): exon 1–13 | ||
5. GPR101 (NM_054021): exon 1; | ||
6. HRAS (NM_005343): exon 2–6; | ||
7. KRAS (NM_004985): exon 2–5; | ||
8. MEN1 (NM_000244): exon 1–10; | ||
9. NRAS (NM_002524): exon 3; | ||
10. PIK3CA (NM_006218): exon 2–21; | ||
11. PRKACB (NM_207578): exon 1–10; | ||
12. PRKAR1A (NM_212471): exon 2–11; | ||
13. RET (NM_020975): exon 2–20; | ||
14. SDHA (NM_004168): exon 2–15; | ||
15. SDHAF2 (NM_017841): exon 1– 4; | ||
16. SDHB (NM_003000): exon 1–8; | ||
17. SDHC (NM_003001): exon 1–6; | ||
18. SDHD (NM_003002): exon 1–4 | ||
SNPs target region chromosome 11 | – rs2513613 | – rs10838307 |
– rs34593780 | – rs4267090 | |
– rs2631403 | – rs7939803 | |
– rs330253 | – rs2887046 | |
– rs73455029 | – rs11233227 | |
– rs7949600 | – rs6483324 | |
– rs1247726 | – rs2851171 | |
– rs4943948 | – rs736287 | |
– rs681017 | – rs2510718 | |
– rs10750552 | – rs1638585 | |
– rs1620333 | – rs7110021 | |
– rs630172 | – rs35787427 | |
– rs481303 | – rs611697 | |
– rs1455113 | ||
SNPs target region chromosome 22 | – rs1970640 | – rs2017869 |
– rs3747031 | – rs1894252 | |
– rs5996639 | – rs956548 | |
– rs2285206 | – rs2038010 | |
– rs2294206 | – rs2143695 | |
– rs62636244 | – rs5769583 | |
– rs17003592 | – rs1296750 | |
– rs3884944 | – rs6010046 |
NM and ENST are both available at http://www.ensembl.org.
DTC differentiated thyroid carcinoma, FFPE formalin-fixed, paraffin-embedded, SNPs single-nucleotide polymorphisms